Journal Articles

PLENVU®

(polyethylene glycol 3350 [140 g], sodium ascorbate [48.11 g], sodium sulfate [9 g], ascorbic acid [7.54 g], sodium chloride [5.2 g] and potassium chloride [2.2 g] for oral solution)

2022

Transient alterations in plasma sodium concentrations with NER1006 bowel preparation: an analysis of three phase III, randomized clinical trials

Cash BD, et al. BMC Gastroenterology. 2022.

2021

Bowel preparation with 1L polyethylene glycol and ascorbate NER1006 doubles the chance to detect three or more adenomas in overweight or obese males

Epstein M, et al. Endosc Int Open. 2021.

Bowel-cleansing efficacy of the 1L polyethylene glycol-based bowel preparation NER1006 (PLENVU) in patient subgroups in two phase III trials 

Baile-Maxia S, et al. Therapeutic Advances in Gastroenterology. 2021.

Patient experience with NER1006 as a bowel preparation for colonoscopy: a prospective, multicenter US survey.  

Cash BD, et al. BMC Gastroenterology. 2021.

2020

High-quality colon cleansing and multiple neoplasia detection with 1L NER1006 versus mid-volume options: post hoc analysis of phase 3 clinical trials

Epstein MS, et al. Endosc Int Open. 2020.

2019

Improved high-quality colon cleansing with 1L NER1006 versus 2L polyethylene glycol + ascorbate or oral sulfate solution 

Repici A, et al. Digestive and Liver Disease. 2019.

Colon cleansing efficacy and safety with 1 L NER1006 versus 2 L polyethylene glycol + ascorbate: a randomized phase 3 trial 

Bisschops R, et al. Endoscopy. 2019.

2018

Novel 1 L polyethylene glycol-based bowel preparation NER1006 for overall and right-sided colon cleansing: a randomized controlled phase 3 trial versus trisulfate 

DeMicco MP, et al. Gastrointestinal Endoscopy. 2018.

Access posters and abstracts
shared during scientific congresses.

Search

*Required field.

Select a product*

Select

Select a therapeutic area*

Select

Enter keyword(s)